植物医生护肤产品
Search documents
聚焦IPO进程:DR PLANT植物医生携生物多样性成果蓄势待发
Jiang Nan Shi Bao· 2026-01-22 08:47
Core Viewpoint - The company, Plant Doctor, emphasizes corporate social responsibility as a core strategy while pursuing its IPO, aligning with the vision of creating a sustainable value system rather than merely focusing on profits [1]. Group 1: Corporate Social Responsibility Initiatives - Plant Doctor has been actively involved in public welfare, launching the "Biodiversity - Alpine Plant Protection Action" in 2017 under the initiative of Professor Pei Shengji, the founder of Chinese Ethnobotany [2]. - The company became a pilot enterprise for the Global Environment Facility (GEF) and the Ministry of Ecology and Environment of China in 2018, and participated in the United Nations Biodiversity Conference (COP14) [2]. - As of now, Plant Doctor has restored 5,590 acres of alpine ecology in Yunnan and established the "Wu Zhengyi Botany Award," the first specialized award in botany globally [2]. Group 2: Engagement in Global Biodiversity Goals - The COP15 conference is crucial for setting new global biodiversity targets and planning protection pathways for the next decade, with Plant Doctor participating in discussions on biodiversity at the Ecological Civilization Forum [2]. - The company signed the "UNDP - Plant Doctor Biodiversity Protection and Sustainable Use Project" in October 2020, becoming the first cosmetics partner in biodiversity protection within the UN system [2]. Group 3: Future Outlook and Commitment - Plant Doctor aims to integrate scientific research and public welfare into its development strategy, reinforcing its commitment to sustainable practices during its IPO process [3]. - The company plans to continue collaborating with various stakeholders to promote harmony between humans and nature, ensuring stability in both capital markets and social responsibility [3].